Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing covers the month of August 2025, specifically detailing a share repurchase executed on August 27, 2025. The company is a Foreign Private Issuer filing under Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing focuses exclusively on capital structure and share repurchase activity. It does not contain revenue, profit, cash flow, or margin data.
- Shares Purchased (August 27, 2025): 260,986 ordinary shares.
- Price Range: Lowest 1,471.00 GBp; Highest 1,484.00 GBp.
- Volume-Weighted Average Price (VWAP): 1,477.76 GBp.
- Trading Venue: London Stock Exchange (XLON).
- Treasury Shares Held: 243,919,716 ordinary shares (post-purchase).
- Shares in Issue (excluding Treasury): 4,071,472,911 ordinary shares.
- Total Voting Rights: 4,071,472,911.
- Treasury Share Voting Percentage: 5.99%.
- Cumulative Buyback (since June 4, 2025): 25,785,333 ordinary shares.
Material Changes
The primary material change is the reduction of shares in issue and the increase in treasury shares resulting from the August 27 transaction. This activity is part of an existing buyback programme initiated via a non-discretionary agreement with Merrill Lynch International on June 4, 2025. The filing does not provide comparative financial performance data against prior periods.
Guidance, Outlook, and Risks
The filing contains no specific financial guidance or management commentary regarding operational outlook. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in GSK's Annual Report on Form 20-F for 2024 and Q2 Results for 2025. No unusual items or contingencies are disclosed in this specific transaction report.
Investor Verification Checklist
- Verify the total number of shares in issue (4,071,472,911) for calculating ownership percentages under Disclosure Guidance and Transparency Rules.
- Confirm the percentage of voting rights held in treasury (5.99%) to assess potential dilution or voting power dynamics.
- Review the cumulative buyback volume (25,785,333 shares since June 4, 2025) to gauge the progress of the capital return programme.
- Check the specific transaction reference numbers provided in the schedule for audit trail verification if required.